Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included b... Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets. Show more
Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and half year ended September 30...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.275 | 1.95799216803 | 14.045 | 14.4 | 13.925 | 1425797 | 14.16613304 | CS |
4 | -63.44 | -81.5843621399 | 77.76 | 78.44 | 13.925 | 696558 | 18.37055641 | CS |
12 | -67.48 | -82.4938875306 | 81.8 | 81.94 | 13.925 | 341597 | 37.15389181 | CS |
26 | -56.11 | -79.6677552179 | 70.43 | 84.46 | 13.925 | 288290 | 54.86205935 | CS |
52 | -53.81 | -78.9813591663 | 68.13 | 84.46 | 13.925 | 257844 | 62.03010318 | CS |
156 | -47.7 | -76.9106739761 | 62.02 | 84.46 | 13.925 | 230486 | 59.69258578 | CS |
260 | -26.23 | -64.6855733662 | 40.55 | 84.46 | 13.925 | 207268 | 59.07018756 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales